Assistance Publique - Hôpitaux de Paris: Infections trials

The registry lists 75 Infections studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 16 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 5Phase 3 12Phase 4 3No phase 55(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae InfectionsNot yet recruitingNCT07631364Phase 3
• Evaluation of Rapid Diagnostic Device for the Detection of Candida AurisRecruitingNCT07253311
• New HBV Infection Biomarkers: Clinical Characterization and Impact on ManagementRecruitingNCT06906016
• Biobank of Samples From Patients With Infectious DiseasesNot yet recruitingNCT06722131
• Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health ProfessionalsRecruitingNCT06694428
• Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)RecruitingNCT06539325Not applicable
• Viral Infection of HSPC Impacts HematopoiesisRecruitingNCT06458504
• Reduction of Antibiotherapy Duration for Infections on Implantable Extra Cardiac Devices LeadsNot yet recruitingNCT06203769Phase 4
• Combination of Leukocyte Cell Surface Biomarkers Measured by Cytometry, to Differentiate Bacterial From Viral Infections in Emergency Department: a Multicentric Cohort for the Validation of Diagnostic PerformancesRecruitingNCT06155266
• Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasisNot yet recruitingNCT06055699
• Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care UnitRecruitingNCT05565222Phase 3
• Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantNot yet recruitingNCT05256693Phase 3
• Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus AureusRecruitingNCT05117398Phase 3
• VACuum-Assisted Closure for Necrotizing Soft Tissue infecTIONsNot yet recruitingNCT05071443Not applicable
• Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)RecruitingNCT04292054Phase 3
• Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis ObliteransRecruitingNCT04099082
• CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 InfectionCompletedNCT04341584Phase 2Results posted
• Study of the Characteristics of Acute Mycoplasma Resuscitation: ECRAN-PLASMA StudyActive, not recruitingNCT07479355
• Infectious Complications After EsophagectomyCompletedNCT06911658
• Severe Group A Streptococcus Infections in Paris, France, 2018-2023CompletedNCT06297122
• Performances of DendrisCHIP®OA in Bone and Joint InfectionsWithdrawnNCT06132347
• Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection RateCompletedNCT05750576Not applicable
• Evaluation of the Impact of the UPLUG Device Onto the Infection Rate of Indwelling Central Venous Catheters in Patients Undergoing Chronic HemodialysisTerminatedNCT05670964Not applicable
• Physiopathology of Prosthetic Joint InfectionsStatus unknownNCT05551572
• Temocillin in ESBL-Enterobacteriaceae InfectionsCompletedNCT05413772
• AMR-DetecTool for the Diagnostic of MDR Bacterial InfectionsCompletedNCT05378217
• Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return HomeCompletedNCT05248490Not applicable
• TTV Viral Load in Heart Transplant RecipientsCompletedNCT05064462
• Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune DiseasesStatus unknownNCT05026892
• Bone Resistant TuberculosisCompletedNCT04928378
• Monoclonal Antibodies in Clostridium Difficile InfectionCompletedNCT04874623Not applicable
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
• RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care UnitCompletedNCT04773704
• Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 InfectionStatus unknownNCT04624997
• Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)CompletedNCT04608214Phase 2
• Efficacy of Nicotine in Preventing COVID-19 InfectionStatus unknownNCT04583410Phase 3
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19CompletedNCT04476979Phase 2
• COVID-19 Infection and Transmission in Exposed, Confined and Community-based InfantsCompletedNCT04413968Not applicable
• COVID-19 Infection in Healthcare WorkersCompletedNCT04386759
• Immunity and Infections in the Psychiatric PopulationStatus unknownNCT04381845Not applicable
• Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it WorseStatus unknownNCT04356417
• Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and NewbornsCompletedNCT04355234Not applicable
• Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.Status unknownNCT04343144Phase 2
• Protective Role of Inhaled Steroids for Covid-19 InfectionTerminatedNCT04331054Phase 3
• ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 PandemicTerminatedNCT04329195Phase 3
• Netosis in Determination of Respiratory Infection SeverityCompletedNCT04318691
• Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ERCompletedNCT04237181Not applicable
• Analysis of the Nasal Mucosal Immune Response in HIV InfectionStatus unknownNCT03920709
• Stress at Work and Infectious Risk in Patients and CaregiversStatus unknownNCT03532321
• Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult InpatientsStatus unknownNCT03460171
• BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICUCompletedNCT03147807Not applicable
• Myelodysplasic Syndromes and Risk Factors for InfectionStatus unknownNCT02905552
• Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic ImplicationsCompletedNCT02890901
• Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular InfectionsCompletedNCT02782078Not applicable
• Comparison of Two Dosage Adjustment Strategies of Vancomycin in ChildrenCompletedNCT02694458Not applicable
• Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65TerminatedNCT02686320
• Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)CompletedNCT02659072
• Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori InfectionStatus unknownNCT02576236Not applicable
• Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract InfectionCompletedNCT02424461Phase 3
• Deescalating Carbapenems in Hospital SettingTerminatedNCT02265445Phase 4
• HIV Patients CohortActive, not recruitingNCT02203006Not applicable
• Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to InfectionsCompletedNCT02010294
• Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA BacteremiaTerminatedNCT01515020Phase 3
• Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)CompletedNCT01500837Not applicable
• Gene Therapy for X-linked Severe Combined ImmunodeficiencyCompletedNCT01410019Phase 1/2
• Molecular Microbiology in Osteo-arthritis InfectionCompletedNCT01193803
• Molecular Detection of Antibiotic Resistance and H Pylori EradicationCompletedNCT01168063Not applicable
• Polyacrylamide Hydrogel Injection in HIV-related LipoatrophyCompletedNCT01077765Phase 3
• In UTERO Treatment of Cytomegalovirus Congenital Infection With ValacyclovirTerminatedNCT01037712Phase 4
• Antibiotic Education for Children in an Emergency Care UnitCompletedNCT00948779Not applicable
• Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 MonthsCompletedNCT00800488
• Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeCompletedNCT00577525
• PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)CompletedNCT00472667Not applicable
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a AntagonistsStatus unknownNCT00224562
• Contrast-Enhanced US of Spleen, Liver and KidneyStatus unknownNCT00190281